Broadly neutralizing antibodies that target epitopes of haemagglutinin on the influenza virus
have the potential to provide near universal protection against influenza virus infection 1 . …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently causing a
global pandemic. The antigen specificity of the antibody response mounted against this novel …

Humans are repeatedly exposed to variants of influenza virus throughout their lifetime. As a
result, preexisting influenza-specific memory B cells can dominate the response after …

Dissecting the evolution of memory B cells (MBCs) against SARS-CoV-2 is critical for
understanding antibody recall upon secondary exposure. Here, we used single-cell sequencing to …

Polyreactivity is the ability of a single antibody to bind to multiple molecularly distinct antigens
and is a common feature of antibodies induced upon pathogen exposure. However, little is …

Broadly neutralizing antibodies are critical for protection against both drifted and shifted
influenza viruses. Here, we reveal that first exposure to the 2009 pandemic H1N1 influenza virus …

Background Convalescent plasma therapy for COVID‐19 relies on transfer of anti‐viral
antibody from donors to recipients via plasma transfusion. The relationship between clinical …

NEIL1 (Nei-like 1) is a DNA repair glycosylase guarding the mammalian genome against
oxidized DNA bases. As the first enzymes in the base-excision repair pathway, glycosylases …

We characterize chemical reduction of a nitroxide biradical, TOTAPOL, used in dynamic
nuclear polarization (DNP) experiments, specifically probing the stability in whole-cell pellets …

Discovery of durable memory B cell (MBC) subsets against neutralizing viral epitopes is
critical for determining immune correlates of protection from SARS-CoV-2 infection. Here, we …